Ly03015
Healthy Participants
Phase I
Completed
A Study of LY03015 in Healthy Chinese and Caucasian Adult Subjects
Apr 14, 2026
―
Ly03017
Negative Symptoms Of Schizophrenia, Hallucinations And Delusions Associated With Alzheimer's Disease Psychosis, Hallucinations And Delusions Associated With Parkinson Disease Psychosis
Phase I
Not Yet Recruiting
A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017
May 12, 2025
Lpm3770164 Sustained Release Tablet Simulant, Lpm3770164 Sustained Release Tablet 5 Mg, Lpm3770164 Sustained Release Tablet 10 Mg, Lpm3770164 Sustained Release Tablet 20 Mg
Tardive Dyskinesia (Td)
Phase I/II
Recruiting
Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia
Dec 09, 2024
Ly03020
Schizophrenia, Alzheimer's Disease Psychosis
Phase I
Completed
A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects
Aug 13, 2024
―
Lpm3770164 Sustained Release Tablet
Tardive Dyskinesia, Huntington Disease
Phase I
Completed
Effect of Food on the Pharmacokinetics of LPM3770164 Sustained-release Tablets
Jun 20, 2024
―
Lpm3770164 Sustained Release Tablet, Lpm3770164 Sustained Release Tablet Simulant
Huntington Disease, Tardive Dyskinesia
Phase I
Completed
Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects
Dec 19, 2023
―
Toludesvenlafaxine Hydrochloride Sustained-Release Tablet 80Mg, Toludesvenlafaxine Hydrochloride Sustained-Release Tablet 160Mg
Generalized Anxiety Disorder
Phase III
Completed
A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder.
Jul 24, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Luye Pharma Group Ltd. (LUP) have in its pipeline
LUP is currently developing the following drugs: Ly03015, Ly03017, Ly03017. These drug candidates are in various stages of clinical development as the company works toward FDA approval.